Novel 3-aryl-1,2-benzisoxazole derivatives, compositions containing same and use thereof

Details for Australian Patent Application No. 2006217799 (hide)

Owner Aventis Pharma S.A.

Inventors Maillet, Patrick; Bertin, Luc; Carrez, Chantal; Thompson, Fabienne; Ruxer, Jean-Marie

Agent A J Park

Pub. Number AU-A-2006217799

PCT Pub. Number WO2006/090052

Priority 0501801 22.02.05 FR

Filing date 20 February 2006

Wipo publication date 31 August 2006

International Classifications

C07D 261/20 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/090052 Priority application(s): WO2006/090052

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006217803-Method for preparing docetaxel

2006217794-Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases